Sino Medical Sciences Technology In - Asset Resilience Ratio
Sino Medical Sciences Technology In (688108) has an Asset Resilience Ratio of 0.66% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Sino Medical Sciences Technology In for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (None–None)
This chart shows how Sino Medical Sciences Technology In's Asset Resilience Ratio has changed over time. See Sino Medical Sciences Technology In (688108) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Sino Medical Sciences Technology In's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sino Medical Sciences Technology In (688108) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥8.54 Million | 0.66% |
| Total Liquid Assets | CN¥8.54 Million | 0.66% |
Asset Resilience Insights
- Limited Liquidity: Sino Medical Sciences Technology In maintains only 0.66% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sino Medical Sciences Technology In Industry Peers by Asset Resilience Ratio
Compare Sino Medical Sciences Technology In's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 36.63% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Kinetic Medical Co
SHE:300326 |
Medical Devices | 28.89% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 48.75% |
|
Aroa Biosurgery Ltd
AU:ARX |
Medical Devices | 12.13% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
Annual Asset Resilience Ratio for Sino Medical Sciences Technology In (None–None)
The table below shows the annual Asset Resilience Ratio data for Sino Medical Sciences Technology In.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Sino Medical Sciences Technology In
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons, intracranial rapid exchange balloons, and intracranial drug-eluting stents. The company was founded in 2007 and is headquartered in Tianjin, China.